Poster Abstract Session:
183. HIV and Co-infections
Saturday, October 5, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Learning Objectives:


Target Audience: academicians

Tracks: HIV-STD-TB


Comparing utilization of inpatient services and hospital outcomes for patients with HIV, HCV, or HIV/HCV
Christine U. Oramasionwu, PharmD, MSc, PhD ; Terence Johnson, BS ; Joshua Toliver, BA, PharmD Candidate
  • IDWeek 2013 Poster FINAL.pdf (459.8 kB)

  • Differences in Demographic, Behavioral and Clinical Characteristics between HCV Mono-infected and HIV Co-infected Adults in Outpatient Primary Care
    Anthony K. Yartel, MPH ; Rebecca L. Morgan, MPH ; David B. Rein, PhD ; Kimberly A. Brown, MD ; Natalie Kil, MPH ; Omar I. Massoud, MD ; Bryce D. Smith, PhD
  • IDSA_PDF_HCV_HIV_4by8_Final.pdf (288.1 kB)

  • Collection Device Comparison for Anal Cancer Screening in HIV-infected Individuals
    Doreen Lee, MD ; Rebecca Levine, MD ; Samer Khader, MD ; Mark Suhrland, MD ; Mimi Kim, ScD ; David Smotkin, MD, PhD ; Robert Burk, MD ; Robert Grossberg, MD ; Mark Einstein, MD, MS

    Absolute CD4 Count and Percentage Discordance Impacting Pneumocystis Jirovecii Pneumonia (PJP) Prophylaxis in HIV-Infected Patients
    Henry Anyimadu, MD, FACP ; Bijal Doshi, MD ; Vel Sivapalan, MD, FACP ; Sharon Mannheimer, MD ; Yael Hirsch-Moverman, PhD

    Seroprevalence and Demographic Determinants of Human T-Lymphotropic Virus Type-1 and -2 Infections among First-time Blood Donors, U.S. 2000-2009
    Yun Brenda Chang, MPH ; Zhanna Kaidarova, MBA ; Daniel Hindes ; Marjorie Bravo ; Nancy Kiely, RN ; Hany Kamel, MD ; Denise Dubay ; Barbara Hoose ; Edward Murphy Jr., MD, MPH
  • Slide1.jpg (184.1 kB)

  • Association Between Hepatitis B Vaccine Antibody Response and CD4 Reconstitution after Initiation of Combination Antiretroviral Therapy in HIV-Infected Individuals
    Kahtonna Allen, DO, MS ; Octavio Mesner, MS ; Anuradha Ganesan, MBBS, MPH ; Jessie Glasser, MD, MPH ; Grace E Macalino, PhD ; Brian Agan, MD ; Jason Okulicz, MD

    Safety and Tolerability of Crofelemer 125 mg Twice Daily in the Treatment of Noninfectious Diarrhea in HIV-Seropositive Patients on Antiretroviral Therapy: Results From a Phase 3, 48-Week Open-Label Study
    Trevor Hawkins, MD ; Rodger Macarthur, M.D. ; Stephen Brown, MD ; Patrick Clay, PharmD, FCCP, CCTI ; Lawrence Waldman, MD ; Andrew Barrett, PhD ; Enoch Bortey, PhD ; Craig Paterson, MD ; William Forbes, PharmD

    Comparing Clinical Outcomes of HIV-infected to HIV-uninfected Older Adults Hospitalized with Community-Acquired Pneumonia
    Lydia Barakat, MD ; Manisha Juthani-Mehta, MD ; Heather Allore, PhD ; Mark Trentalange, MD, MPH ; Janet P. Tate, MPH ; David Rimland, MD ; Kristina Crothers, MD ; Amy Justice, MD ; Vincent Quagliarello, MD, FIDSA

    High Patient Turnover in a Large Public HIV Clinic and its Association with Mortality
    Edward Gardner, MD ; Margaret Mclees, MD ; Robert Beum, CCP ; Juanita Lovato ; Moises Maravi, BS, MSc ; William Burman, MD

    Hepatitis C Virus Diversity and Liver Disease Development in HIV/HCV Co-infected Women
    Jiaao Xu, MBBS ; Eva Operskalski, PhD ; Hui Zhou, MS ; Wendy J. Mack, PhD ; Roksana Karim, PhD, MBBS ; Barbara Weiser, MD ; Harold Burger, PhD, MD ; Mark H. Kuniholm, PhD ; Brian Edlin, MD ; Chenglong Liu, MD, PhD ; Marion G. Peters, MD ; Audrey French, MD ; Elizabeth T. Golub, PhD ; Gerald B. Sharp, DrPH ; Andrea Kovacs, MD
  • 42589_IDWPOSTER_update.pdf (2.5 MB)

  • Declining rates of HIV-TB co-infection in British Columbia and the efficacy of current Canadian tuberculosis screening practices in the HAART era
    Matthew Pellan Cheng, M.D., C.M. ; Alim Hirji, M.D. ; Victoria Cook, M.D. ; David Roth, M.Sc ; James Johnston, MD
  • HIV & TB - IDSA.pdf (687.2 kB)

  • HIV-1 subtypes and antiretroviral resistance mutations in HBV/HCV co-infected HIV-1 positive patients in Turkey
    Murat Sayan, associate prof.dr. ; Sila Akhan, Prof.Dr. ; Fatma Sargin, MD ; Atahan Cagatay ; Hayati Demiraslan ; Elif Altunok ; Aynur Aynioglu
  • HIV poster idsa silaakhan.pdf (231.4 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.